GILEAD SCIENCES INC (GIS.DE) Stock Fundamental Analysis

FRA:GIS • US3755581036

125.48 EUR
+3.28 (+2.68%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GIS. GIS was compared to 77 industry peers in the Biotechnology industry. GIS scores excellent on profitability, but there are some minor concerns on its financial health. GIS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year GIS was profitable.
  • GIS had a positive operating cash flow in the past year.
  • GIS had positive earnings in 4 of the past 5 years.
  • Of the past 5 years GIS 4 years had a positive operating cash flow.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • With an excellent Return On Assets value of 13.86%, GIS belongs to the best of the industry, outperforming 88.31% of the companies in the same industry.
  • GIS has a Return On Equity of 37.80%. This is amongst the best in the industry. GIS outperforms 97.40% of its industry peers.
  • GIS has a better Return On Invested Capital (18.54%) than 97.40% of its industry peers.
  • GIS had an Average Return On Invested Capital over the past 3 years of 16.22%. This is above the industry average of 11.65%.
  • The 3 year average ROIC (16.22%) for GIS is below the current ROIC(18.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • The Profit Margin of GIS (27.88%) is better than 85.71% of its industry peers.
  • GIS's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 38.96%, GIS belongs to the top of the industry, outperforming 96.10% of the companies in the same industry.
  • GIS's Operating Margin has improved in the last couple of years.
  • GIS's Gross Margin of 78.72% is fine compared to the rest of the industry. GIS outperforms 68.83% of its industry peers.
  • In the last couple of years the Gross Margin of GIS has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GIS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for GIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • GIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.32
WACC7.99%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that GIS should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.53, GIS is in line with its industry, outperforming 40.26% of the companies in the same industry.
  • A Quick Ratio of 1.17 indicates that GIS should not have too much problems paying its short term obligations.
  • The Quick ratio of GIS (1.17) is worse than 62.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • Measured over the past 5 years, GIS shows a small growth in Earnings Per Share. The EPS has been growing by 2.83% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.47% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.32% on average over the next years.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.19 indicates a rather expensive valuation of GIS.
  • Based on the Price/Earnings ratio, GIS is valued cheaply inside the industry as 88.31% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, GIS is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 16.62, which indicates a correct valuation of GIS.
  • GIS's Price/Forward Earnings ratio is rather cheap when compared to the industry. GIS is cheaper than 93.51% of the companies in the same industry.
  • GIS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 18.19
Fwd PE 16.62
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GIS is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, GIS is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.32
EV/EBITDA 12.04
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIS does not grow enough to justify the current Price/Earnings ratio.
  • GIS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.93
PEG (5Y)6.44
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • GIS has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
  • GIS's Dividend Yield is rather good when compared to the industry average which is at 0.47. GIS pays more dividend than 96.10% of the companies in the same industry.
  • GIS's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr Years6
Div Non Decr Years6
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • GIS pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of GIS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

FRA:GIS (2/27/2026, 7:00:00 PM)

125.48

+3.28 (+2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap155.68B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.62
Price Target120.14 (-4.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.65
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)4.03%
PT rev (3m)5.57%
EPS NQ rev (1m)-2.06%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 18.19
Fwd PE 16.62
P/S 6.32
P/FCF 19.32
P/OCF 19.03
P/B 8.57
P/tB N/A
EV/EBITDA 12.04
EPS(TTM)6.9
EY5.5%
EPS(NY)7.55
Fwd EY6.02%
FCF(TTM)6.5
FCFY5.18%
OCF(TTM)6.6
OCFY5.26%
SpS19.84
BVpS14.64
TBVpS-3.29
PEG (NY)1.93
PEG (5Y)6.44
Graham Number47.67
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC7.99%
ROIC/WACC2.32
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / GIS.DE FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 6 / 10 to GIS.DE.


What is the valuation status of GILEAD SCIENCES INC (GIS.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GIS.DE) stock?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 8 / 10.


What is the financial health of GILEAD SCIENCES INC (GIS.DE) stock?

The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 5 / 10.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 9.44% in the next year.